Piper Sandler initiated coverage on Omega Therapeutics with a new price target
$OMGA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Piper Sandler initiated coverage of Omega Therapeutics with a rating of Overweight and set a new price target of $30.00